2 news items
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
JAZZ
1 Jun 24
meaningful benefits of sustained and durable responses with continued treatment with zanidatamab.
"Patients
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
ABBV
CRBP
CRDL
14 May 24
sustainable and pure cannabinoid products.
Cardiol Therapeutics Inc
- Prev
- 1
- Next